A synoptic framework and future directions for placental pathology reporting.


Journal

Placenta
ISSN: 1532-3102
Titre abrégé: Placenta
Pays: Netherlands
ID NLM: 8006349

Informations de publication

Date de publication:
02 2019
Historique:
received: 06 09 2018
revised: 06 01 2019
accepted: 08 01 2019
entrez: 5 3 2019
pubmed: 5 3 2019
medline: 4 4 2020
Statut: ppublish

Résumé

Placental pathology is a key modality for determining placental health during pregnancy, especially in the event of adverse pregnancy outcomes. However, issues with standardization in placental diagnosis, reporting practices and clinical translation prevent this modality from being used to its full potential. This article will highlight these standardization issues and summarize ongoing work in this field to overcome them. Additionally, we propose a synoptic reporting framework for placental pathology based on current consensus guidelines, aimed at enhancing the comprehensiveness and quality of reporting placental findings. We believe this approach will improve our understanding of the placenta in adverse pregnancy outcomes and, importantly, offer the opportunity to increase knowledge translation to key stakeholder groups including patients.

Identifiants

pubmed: 30827355
pii: S0143-4004(18)31030-0
doi: 10.1016/j.placenta.2019.01.009
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

46-57

Subventions

Organisme : CIHR
ID : 130543CIA
Pays : Canada

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Samantha J Benton (SJ)

Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada.

Anthea J Lafreniere (AJ)

Department of Anatomical Pathology, The Ottawa Hospital, Faculty of Medicine, University of Ottawa, Ottawa, Canada.

David Grynspan (D)

Department of Pathology, Children's Hospital of Eastern Ontario, Ottawa, Canada. Electronic address: dgrynspan@cheo.on.ca.

Shannon A Bainbridge (SA)

Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada; Interdisciplinary School of Health Sciences, Faculty of Health Sciences, University of Ottawa, Ottawa, Canada. Electronic address: shannon.bainbridge@uottawa.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH